Biocompatible Hydrogel Enzyme Immobilization via Non-Covalent Confinement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for enzyme stabilization and immobilization in hydrogels face challenges such as limited enzyme lifetime, toxicity from used chemicals, and instability of hydrogel bonds, leading to premature degradation and leaching of enzymes.
Innovation Solution
A biocompatible hydrogel is prepared using a method that involves functionalizing polysaccharides with specific linker units, allowing for non-covalent immobilization of enzymes without the need for toxic chemicals, thereby providing a stable and protective environment for the enzymes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If covalent modification is used for enzyme encapsulation, then enzyme immobilization is achieved, but enzyme activity is impaired
Solution Approach 1:
The patent introduces a hydrogel matrix as an intermediary medium that provides physical encapsulation of enzymes through non-covalent interactions (adsorption, entrapment, confinement) rather than direct covalent bonding. This mediator protects enzymes while preserving their native active sites and catalytic function.
Solution Approach 2:
The patent replaces chemical covalent bonding mechanisms with physical confinement mechanisms. The hydrogel network provides a three-dimensional matrix that traps enzymes through size exclusion and physical entrapment, substituting the need for chemical crosslinking that would modify enzyme structures.
2Stability of the object's composition
If glutaraldehyde is used for crosslinking, then hydrogel stability is improved, but toxicity and covalent modification of enzymes occur
Solution Approach 1:
The patent employs transient physical interactions and reversible non-covalent bonds within the hydrogel matrix, avoiding the use of persistent toxic crosslinking agents like glutaraldehyde. The hydrogel provides temporary protective confinement without requiring harmful chemical stabilizers.
Solution Approach 2:
The patent converts the potential harm of unstable hydrogel structures into benefit by using controlled physical confinement and non-covalent interactions that provide sufficient stability without toxicity. The hydrogel matrix itself becomes the protective element rather than relying on toxic crosslinkers.
3Ease of manufacture
If Schiff base formation is used for hydrogel preparation, then gelation is achieved, but reversibility and toxicity occur
Solution Approach 1:
The patent extracts and eliminates the problematic Schiff base chemistry from the hydrogel formation process. Instead, it uses alternative non-covalent mechanisms such as physical entrapment, adsorption, and confinement within the hydrogel network to achieve enzyme immobilization without relying on reversible imine linkages.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed method significantly enhances enzyme stability and lifetime, prevents biofouling and immune response, and maintains enzymatic activity even in organic solvents, while avoiding the use of toxic reagents.
Implementation Method 1
The hydrogel according to the present invention provides a perfect stabilizing environment for the enzyme, resulting in a better lifetime and enzyme stability. The hydrogel according to the present invention protects the enzyme from biofouling and body immune response.
Implementation Method 2
Different methods have been developed to immobilize enzymes in a hydrogel network... The present invention describes a novel strategy to immobilize enzymes in a biocompatible hydrogel that does not require a covalent binding of one or more enzyme(s).
Data Source
AI summary
The invention provides a method of preparing a biocompatible hydrogel, a hydrogel obtainable by that method, a biocompatible hydrogel for non-covalent immobilization of one or more enzyme(s), and a composition including any of those hydrogels. The invention further provides a method for encapsulating one or more enzyme(s) in a hydrogel as described herein and the use of any of said hydrogels for non-covalent immobilization of one or more enzyme(s) in the hydrogel or the use of any of said hydrogels in a biosensor. Additionally, the present invention provides a kit containing the composition or the hydrogel according to the present invention.